Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKinsey
Colorcon
Baxter
Express Scripts

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,939,559

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,939,559 protect, and when does it expire?

Patent 6,939,559 protects OMNARIS and is included in one NDA.

This patent has fifty patent family members in thirty-five countries.

Summary for Patent: 6,939,559
Title: Pharmaceutical composition for application to mucosa
Abstract:The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to efficient and high permeability to the blood at the mucosa. The present invention further provides a pharmaceutical composition for application to the mucosa comprising a hemostatic agent and a medicament. This composition is superior over conventional pharmaceutical compositions for application to the mucosa, due to permeability and retentivity at the mucosa.
Inventor(s): Nishibe; Yoshihisa (Hino, JP), Kinoshita; Wataru (Hino, JP), Kawabe; Hiroyuki (Tokyo, JP)
Assignee: Teijin Limited (Osaka, JP)
Application Number:09/446,276
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 6,939,559

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Covis Pharma Bv OMNARIS ciclesonide SPRAY, METERED;NASAL 022004-001 Oct 20, 2006 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,939,559

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan10-110887Apr 21, 1998
Japan10-110888Apr 21, 1998
PCT Information
PCT FiledApril 21, 1999PCT Application Number:PCT/JP99/02126
PCT Publication Date:October 28, 1999PCT Publication Number: WO99/53899

International Family Members for US Patent 6,939,559

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 336986   Start Trial
Australia 3534399   Start Trial
Australia 757772   Start Trial
Bulgaria 104020   Start Trial
Bulgaria 64919   Start Trial
Brazil 9906372   Start Trial
Brazil PI9906372   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.